Additionally, PDE4 inhibition potentiated the cAMP production in response to PGE2 at 5 min in SSc skin MFs (Figure 4C), suggesting that PDE4‐mediated cAMP degradation may also contribute to PGE2 resistance within SSc skin MFs. Here, PDE4A is linked to systemic sclerosis.